Life Sciences Archive » June, 2011

Life Sciences - June, 2011

176 articles

• Medicare Will Cover Avastin Despite FDA Ruling
• Elan, Abbott Drop Teva Patent Suit Over Tricor
• ViiV Goes After Lupin Over HIV Drug ANDA
• Ex-Ropes & Gray Atty Gets 30 Months In Prison
• Mercedes, T. Rowe Price Settle Web Patent Claims
• Merck, Sandoz Resolve Patent Suit Over Cancidas
• Impax Settles With Daiichi, Genzyme Over Generic Welchol
• Signalife, Investors Seek Approval For $4M Settlement
• Ex-Bio-Med Execs Can't Escape Convictions: 11th Circ.
• Somaxon Sues Mylan Again Over Generic Silenor
• FDA Panel Rules Avastin Unsafe For Breast Cancer Use
• EU, South Korea FTA To Address Nontariff Barriers
• Wilson Sonsini Snags Pharma Patent Pro From Foley
• Getting Specific About FCPA Compliance
• Doctors Blast Rosy Research For Medtronic Bone Device
• Judge Agrees With Watson's Take On Lidoderm Patent
• Roche Files 3 Patent Suits Over Generic Xeloda
• Pfizer Fights Aurobindo's Bid To Sell Generic Lipitor
• Medtronic Sues Edwards Over Heart Valve Patents
• Icahn Sues Forest Labs Over CEO Defense
• Mylan Takes $76M Antitrust Verdict To High Court
• UnitedHealth Seeks 2nd Remand Of GSK Paxil Action
• APP Takes Patent Contract Ruling To High Court
• AstraZeneca Sues Watson Over Generic Pulmicort
• Questions Remain On Class Certification Relitigation
• Zyprexa Payors' Off-Label Suit Denied By High Court
• Prandin Use Code Case Taken Up By High Court
• Atty Can't Represent AWP Classes, 1st Circ. Rules
• FDA Strengthens Warnings On Amgen, J&J Anemia Drugs
• W.Va. Supreme Court Revives Mylan Forum Challenge
• St. Jude Wins Injunction, Verdict Trimmed By $1.3B
• LeClairRyan Adds Roetzel White Collar Atty In DC
• 2nd Circ. Nixes $1.3B Asthma Drug Suit V. AstraZeneca
• Mylan Crohn's Drug Doesn't Infringe AstraZeneca IP: Judge
• Novelos Shakes Class Action Over Cancer Drug Statements
• UnitedHealth Wins Access To GSK Litigation Info
• Novo Hit With Overtime, Break Action From Sales Rep
• Teva Targets Apotex Over Generic Parkinson's Drug
• GSK To Pay States, DC $41M Over Drugmaking Lapses
• High Court Ruling May Hobble Suits Against Generics
• Smith & Nephew Wins $85M IP Verdict Against Arthrex
• Covidien Sales Rep OT Suit Should Be Certified: Judge
• Hospira Sued Over Infusion Patent, Sale Contract
• Feds Seek 30 Years For Doctor In $23M Medicare Fraud
• Mylan Resolves Shire Suit Over Generic Fosrenol
• Ex-'Biggest Loser' Hopeful Wraps Up Feud With Diet Cos.
• Fed. Circ. Affirms Invalidity Of Tyco Restoril Patent
• Breast Implants Aren't Forever, FDA Warns
• Understanding The Advice-Of-Counsel Defense
• Judge OKs Replacement Of Dead Class Rep In Paxil Suit
• Sens. Order Medtronic To Turn Over Infuse Records
• Skadden Reps Dentsply In $1.8B AstraZeneca Unit Buy
• Nationwide Bias Actions Are DOA Post-Dukes
• IP Cases To Watch At The District Court Level
• Claims Cut From Ex-Eisai Worker's Whistleblower Suit
• FDA Wants Relaxed Sterility Test Rules For Bio Products
• 25 Percent, 50 Percent ... What's In A Number?
• The FTC's War On 'Pay-For-Delay' Agreements
• Astellas Hits Sagent, Strides With Adenoscan IP Suit
• Sanofi Takes Sun To Court Over Generic Eloxatin
• Depomed Fights Generic Threat To Glumetza
• FDA Implements 9 Graphic Cigarette Warning Labels
• Richards Layton IT Guy Settles SEC Fraud Claims
• Wyeth Settles Patent Suit Over Generic Effexor
• Owner Of Ill. Weight Loss Clinics Charged With Fraud
• Fed. Circ. Tosses $5M Award Over Knee Surgery Patent
• High Court Declines To Weigh In On Patent Definiteness
• Supreme Court To Weigh Patentability Again In Mayo Case
• GSK Sues Roxane, Watson Over Generic Avodart
• J&J Wins 1st Trial Victory In Levaquin MDL
• High Court Won't Review $58M Award In Wyeth Drug Suit
• Fed. Circ. Stops Launch Of Watson's Generic Seasonique
• ITC Takes Up CSP's 337 Complaint Against Sued-Chemie
• How They Won It: Morgan Lewis Snags $577M Verdict For Asahi
• J&J Unit Recalls 40,000 Bottles Of Risperidone
• FDA Calls Back Boston Scientific Stents, Catheters
• HHS Wrongly Denied Hospital Reimbursements: DC Circ.
• J&J Faces Suit Over Benecol Cholesterol Claims
• AstraZeneca Drops Suit After Teva Nixes Generic Faslodex
• ThyssenKrupp Unit Settles With DOL In Sex Bias Row
• Judge Won't Block Watson's Generic Seasonique
• ConocoPhillips Unit Sues Trucking Co. Over PCB Cleanup
• How They Won It: Steptoe Gets Rare Acquittal For GSK Atty
• Somaxon Sues Zydus Over Generic Silenor
• GSK's Rotavirus Vaccine Tied To Bowel Disorder
• Q&A With Locke Lord's Graham Hill
• AGA Hits Occlutech With IP Suits In Germany, UK
• Inside Smith V. Bayer
• NY Court Refuses To Step Between Prosecutors, Amgen
• FDA Says Chantix Raises Risk Of Heart Attacks
• High Court Greenlights W.Va. Class Bid In Baycol Fight
• Apotex Can't Dodge Schering Suit Over Nasonex IP
• Ex-DHB Execs Face $150M Forfeiture For Stock Scheme
• 8th Circ. Weighs Women's Right To Pursue Wyeth Claims
• Novartis, Roxane Settle Famvir Dispute
• GSK Shakes Humana Suit Over Avandia Injury Costs
• FDA Widens Recall Of Boston Scientific Catheters
• Q&A With Fish & Richardson's John Adkisson
• Exec Says US Can't Prove Intent In Bone Cement Case
• Q&A With Dechert's Steven Weisburd
• 3rd Circ. Affirms Dismissal Of Amgen Tying Suit
• FDA Warns Matrixx Over Zicam Marketing
• 9th Circ. Refuses To Rehear Pfizer-Wyeth Merger Suit
• Novartis, Sun Settle IP Suit Over Generic Focalin
• FTC Seeks More Details On Teva's $6.8B Cephalon Buy
• Alcon Sues Watson To Block Pataday Generic
• Wis. Drug Cos. Face Temporary Shutdown After Raid
• Global 20: Reed Smith
• DOJ Subpoenas Gilead Over HIV Drugs
• Humira Patient Sues Abbott Over Fungal Infection
• Extra Damages Possible In $22M Stent Suit: Fed. Circ.
• Davis Polk Reps Aetna In $290M Genworth Buy
• Ex-Pfizer Reps Seek Classes For NY, Calif., Ill.
• Germany Suspends Takeda Diabetes Drug Actos
• Pharma Holdings Defendants Get 10 Days To Yield Docs
• Novo Settles Drug Marketing Claims For $26.7M
• FDA Says Prostate Drugs Can Cause Cancer
• Pfizer Sanctions Affirmed In Neurontin Antitrust MDL
• Whistleblower Protections Restored: Sylvester V. Parexel
• Warner Chilcott Sues Mylan Over Loestrin ANDA
• Jury Finds Against Baxter In Chinese Heparin Suit
• IP Lawyers Weigh In On Microsoft V. I4i Ruling
• Zocor Dangerous In High Doses, FDA Warns
• Cos. Brace For Calif. Green Chemistry Program
• FDA Takes First Step Toward Regulating Nanotechnology
• Roche, Genentech Sued Over Encryption Patent
• EU Court Adviser Sides With Merck In Patent Term Fight
• 2nd Circ. Affirms $11M Hit Against Taro Insider Traders
• UCB Agrees To Pay $34M Over Epilepsy Drug Labeling
• Lilly Sues Hetero To Block Generic Strattera
• Schering-Plough Denied Injunction In Sunscreen Suit
• Medical Food Makers Settle False Advertising Suit
• Lilly Wins TRO Battle In Byetta Marketing Case
• Global 20: Skadden
• Pfizer Unit Yanks Poultry Drug After FDA Arsenic Study
• 8th Circ. Again Upholds Catheter Maker's Antitrust Win
• Lawyer Dad Settles SEC Insider Trading Suit
• WellPoint Buys CareMore In Reported $800M Deal
• Forest Labs Sales Reps Win Class Cert. In OT Suit
• Firm Lied To Vioxx MDL Clients About Loans, Suit Says
• Global 20: Weil Gotshal & Manges
• Lundbeck Settles Antitrust Suit Over Infant Heart Drugs
• Fed. Circ. Affirms Invalidity Of J&J Stent Patents
• Be Careful What You Wish For, You Just Might GIT It
• Clarifying Obligation To Report Drug Patent Agreements
• Prior Art, Bird Feeder Not Comparable: Fed. Circ.
• 7th Circ. Questions Ex-Abbott Workers' ERISA Suit Bid
• McKesson, Hearst Inflated Drug Prices, Mich. AG Says
• AstraZeneca Settles DOL Sex Bias Pay Dispute
• FDA Warns Impax Over Drug Testing At Calif. Plant
• SEC Says Calif. Atty Stole Info On $2.8B Abbott Deal
• J&J Ordered To Pay $327M Over Risperdal Marketing
• Takeda Drops Suit Over Macleods' Actos ANDA
• Matrixx, Zicam Fail To Shut Down Cold Remedy MDL
• Lockheed Finds Way Out Of DataTern Patent Suit
• American Medical Settles Suits Over $2.9B Endo Buy
• Calif. County Seeks To Give US Drug Price-Fixing Docs
• Hearst Says Marie Claire Site Doesn't Violate Web Patent
• Pfizer Sues Watson Over Viagra ANDA
• GSK Denied Quick Win In Flonase Antitrust Cases
• SEC Widens Insider Trading Case Against FDA Chemist
• J&J Supplier Bugs Out Over Beetles In Bandages
• Pfizer Sues Impax Over Detrol ANDA
• Zicam Inventor Arrested Over Unapproved Bird Flu Drug
• Squire Sanders Nabs Health Care Prosecutor
• Ropes & Gray Snags Former Assistant US Atty
• Orthovita Shareholders Sue Over $316M Stryker Deal
• Goodell DeVries Opens Pa. Office With Ex-Dechert Attys
• Cooley Hires M&A Veteran From SNR Denton
• Implications Of Fed. Circ.'s Therasense Opinion
• Becton To Take Inequitable Conduct Fight To High Court
• Endo Sales Reps Win Conditional Cert. For OT Suit
• Allergan, Hi-Tech Settle IP Case Over Generic Combigan
• ReGen Sues FDA Over Menaflex Clearance Repeal
• Hydroxycut MDL Claims Fall Short, Judge Says
• FTC Signs Off On Grifols-Talecris Deal Divestitures